NEW YORK, November 28, 2020 / PRNewswire / – Rosen Law Firm, a global investor rights law firm, reminds buyers of securities of Mesoblast Limited (NASDAQ: MESO) between April 16, 2019 and October 1, 2020, including (the “Recourse Period”), December 7, 2020 Lead Complainant’s Delay in Securities Class Action The lawsuit seeks to recover damages for Mesoblast investors under federal securities laws.
To join the Mesoblast class action, go to http://www.rosenlegal.com/cases-register-1923.html or call Phillip Kim, Esq. toll free at 866-767-3653 or by email [email protected] or [email protected] for more information on collective action.
According to the lawsuit, the defendants throughout the trial period made false and / or misleading statements and / or failed to disclose that: (1) comparative analyzes between the Phase 3 trial of Mesoblast and three studies History did not support the efficacy of remestemcel-L for steroid acute refractory graft-versus-host disease (“aGVHD”) due to design differences between the four studies; (2) therefore, the United States Food and Drug Administration was reasonably likely to require additional clinical studies; (3) therefore, the marketing of remestemcel-L in the United States would likely be delayed; and (4) as a result of the foregoing, the defendants’ positive statements about the business, operations and prospects of Mesoblast were materially misleading and / or lacking reasonable basis. When the real details entered the market, the lawsuit claims that investors have suffered damage.
A class action has already been filed. If you want to become the principal applicant, you must move the court not later than December 7, 2020. A principal plaintiff is a representative party acting on behalf of the other members of the group in the direction of the litigation. If you would like to join the litigation, please visit http://www.rosenlegal.com/cases-register-1923.html or to discuss your rights or interests regarding this class action lawsuit, please contact Phillip Kim, Esq. from Rosen law firm toll free at 866-767-3653 or by e-mail at [email protected] or [email protected].
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY A LAWYER UNLESS YOU KEEP ONE. YOU CAN RETAIN ANY ADVICE OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT MEMBER AND DO NOTHING AT THIS POINT. THE ABILITY OF AN INVESTOR TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT ON HIS ACTING AS LEADING PLAINTIFF.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Rosen Law Firm represents investors worldwide, focusing its practice in securities class actions and derivative shareholder litigation. Rosen Law Firm was ranked # 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has been ranked in the top 3 every year since 2013. Rosen Law Firm has achieved the greatest settlement of a class action lawsuit against a Chinese company. Rosen Law Firm attorneys are ranked and recognized by many independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Lawyer advertising. Previous results do not guarantee a similar result.
——————————-
Contact information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Rosen, PA Law Firm
275 Madison Avenue, 40th Floor
New York, NY 10016
Phone: (212) 686-1060
Toll free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com
SOURCE Rosen, PA Law Firm
Related links
www.rosenlegal.com
